IPVS POLICY STATEMENT ON HPV NUCLEIC ACID TESTING guidance for those utilising/considering HPV as primary precancer screening: Quality Assurance and Quality Control issues

Garland, Suzanne M.; Iftner, Thomas; Cuschieri, Kate; Kaufmann, Andreas M; Arbyn, Marc; de Sanjose, Silvia; Poljak, Mario; Dillner, Joakim; Unger, Elizabeth R.

doi:10.1016/j.jcv.2022.105349

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

IPVS POLICY STATEMENT ON HPV NUCLEIC ACID TESTING guidance for those utilising/considering HPV as primary precancer screening: Quality Assurance and Quality Control issues

2-2023
By Garland, Suzanne M. ; Iftner, Thomas ; Cuschieri, Kate ; ...
http://dx.doi.org/10.1016/j.jcv.2022.105349
Source: J Clin Virol. 159:105349

[PDF-327.79 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

J Clin Virol
Personal Author:

Garland, Suzanne M. ; Iftner, Thomas ; Cuschieri, Kate ; Kaufmann, Andreas M ; Arbyn, Marc ; ... More +

Garland, Suzanne M. ; Iftner, Thomas ; Cuschieri, Kate ; Kaufmann, Andreas M ; Arbyn, Marc ; de Sanjose, Silvia ; Poljak, Mario ; Dillner, Joakim ; Unger, Elizabeth R. Less -
Corporate Authors:

IPVS Policy Committee GarlandSuzanne MabcStanleyMargaretmMoscickiAnna-BarbaranWooYin LingoBhatlaNeerjapChanKaren L.qPalefskyJoelrGiulianoAnna RsKaufmannAndreasgde SanjoseSilviaiBrothertonJulia M.L.tuFeldmanSarahv
Description:

We advise that only clinically validated HPV assays which have fulfilled internationally accepted performance criteria be used for primary cervical screening. Further, assays should be demonstrated to be fit for purpose in the laboratory in which they will ultimately be performed, and quality materials manuals and frameworks will be helpful in this endeavor. Importantly, there is a fundamental shortage of well validated, low-cost, low complexity HPV tests that have demonstrated utility in a near-patient setting; representing a significant challenge and focus for future development in order to reach the WHO's goal of eliminating cervical cancer.
Subjects:

[+]

Early Detection Of Cancer Female Humans Mass Screening Nucleic Acids Papillomaviridae Papillomavirus Infections Policy Quality Control Uterine Cervical Neoplasms
Keywords:

[+]

Cervical HPV Primary Screening Validation
Source:

J Clin Virol. 159:105349
Pubmed ID:

36584621
Pubmed Central ID:

PMC11391586
Document Type:

Journal Article
Funding:

CC999999/ImCDC/Intramural CDC HHSUnited States/
Volume:

159
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha-512:7406302e56b6a49a39af0832a8d68f24d709d72d2ecada71968c036d8f596ad9e87e801dde0f187519b66a193b67dfaa1871b856579fb038c4e3e9845d898d95
Download URL:

https://stacks.cdc.gov/view/cdc/162398/cdc_162398_DS1.pdf
File Type:

nihms-2018758.nxml

xml

More +